These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12049765)

  • 1. An essential function of AP-1 heterodimers in Drosophila development.
    Ciapponi L; Bohmann D
    Mech Dev; 2002 Jul; 115(1-2):35-40. PubMed ID: 12049765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
    van Dam H; Castellazzi M
    Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interactions between Drosophila melanogaster menin and Jun/Fos.
    Cerrato A; Parisi M; Santa Anna S; Missirlis F; Guru S; Agarwal S; Sturgill D; Talbot T; Spiegel A; Collins F; Chandrasekharappa S; Marx S; Oliver B
    Dev Biol; 2006 Oct; 298(1):59-70. PubMed ID: 16930585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
    Leonard DA; Rajaram N; Kerppola TK
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer.
    Mohamed MK; Tung L; Takimoto GS; Horwitz KB
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):241-50. PubMed ID: 7826885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of Zic3 by heterodimeric AP-1(c-Jun/c-Fos) during Xenopus development.
    Lee SY; Lee HS; Moon JS; Kim JI; Park JB; Lee JY; Park MJ; Kim J
    Exp Mol Med; 2004 Oct; 36(5):468-75. PubMed ID: 15557819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH; Chen TK; Birrer MJ
    Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semirational design of Jun-Fos coiled coils with increased affinity: Universal implications for leucine zipper prediction and design.
    Mason JM; Schmitz MA; Müller KM; Arndt KM
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8989-94. PubMed ID: 16754880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila.
    Jindra M; Gaziova I; Uhlirova M; Okabe M; Hiromi Y; Hirose S
    EMBO J; 2004 Sep; 23(17):3538-47. PubMed ID: 15306851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding and transactivation properties of Fos variants with homodimerization capacity.
    Porte D; Oertel-Buchheit P; John M; Granger-Schnarr M; Schnarr M
    Nucleic Acids Res; 1997 Aug; 25(15):3026-33. PubMed ID: 9304112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation.
    Tillman K; Oberfield JL; Shen XQ; Bubulya A; Shemshedini L
    Endocrine; 1998 Oct; 9(2):193-200. PubMed ID: 9867253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1--Introductory remarks.
    Wagner EF
    Oncogene; 2001 Apr; 20(19):2334-5. PubMed ID: 11402330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Fos-silization.
    Weitzman J
    Trends Mol Med; 2001 Jan; 7(1):10. PubMed ID: 11427972
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction, purification, and characterization of a hybrid protein comprising the DNA binding domain of the LexA repressor and the Jun leucine zipper: a circular dichroism and mutagenesis study.
    Schmidt-Dörr T; Oertel-Buchheit P; Pernelle C; Bracco L; Schnarr M; Granger-Schnarr M
    Biochemistry; 1991 Oct; 30(40):9657-64. PubMed ID: 1911752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and composition of activator protein 1 (AP-1) transcription factors controlling collagenase and c-Jun promoter activities.
    Steinmüller L; Cibelli G; Moll JR; Vinson C; Thiel G
    Biochem J; 2001 Dec; 360(Pt 3):599-607. PubMed ID: 11736649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.